Wendy Young
Net worth: 592 386 $ as of 30/09/2026
Net worth: 592 386 $ as of 30/09/2026
Dr. Wendy B. Young is an Independent Director at Rapport Therapeutics, Inc., an Independent Director at Azora Therapeutics, Inc., an Independent Director at Terray Therapeutics, Inc. and an Independent Director at Think Bioscience, Inc. She is on the Board of Directors at Rapport Therapeutics, Inc., Azora Therapeutics, Inc., Terray Therapeutics, Inc. and Think Bioscience, Inc. Dr. Young was previously employed as an Independent Director by Adial Pharmaceuticals, Inc., a Chief Executive Officer by Stealth Co., a Senior Vice President-Drug Discovery by Genentech, Inc., and an Executive Partner by MPM BioImpact LLC.
She received her undergraduate degree from Wake Forest University, a graduate degree from Wake Forest University and a doctorate degree from Princeton University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 22/10/2026 | 13,289 ( 0.03% ) | 446 510 $ | 30/09/2026 | |
1.39% | 17/09/2026 | 36,378 ( 1.39% ) | 145 876 $ | 30/09/2026 |
| Companies | Position | Start |
|---|---|---|
| RAPPORT THERAPEUTICS, INC. | Director/Board Member | 07/11/2024 |
Terray Therapeutics, Inc.
Terray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops treatment for human diseases using spatially encoded screening optimization platform | Director/Board Member | - |
Think Bioscience, Inc.
Think Bioscience, Inc. BiotechnologyHealth Technology Develops small-molecule drugs | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
Stealth Co.
Stealth Co. Miscellaneous Commercial ServicesCommercial Services Operates as a sustainable personal care company intended to reduce environmental impact | Chief Executive Officer | 02/06/2023 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 02/09/2021 |
| ADIL PHARPAR | Director/Board Member | - |
MPM BioImpact LLC
MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 9 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Adial Pharmaceuticals, Inc.
Adial Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medications to treat addiction and related disorders | Health Technology |
MPM BioImpact LLC
MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
Wake Forest University
Wake Forest University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Terray Therapeutics, Inc.
Terray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops treatment for human diseases using spatially encoded screening optimization platform | Commercial Services |
Stealth Co.
Stealth Co. Miscellaneous Commercial ServicesCommercial Services Operates as a sustainable personal care company intended to reduce environmental impact | Commercial Services |
Think Bioscience, Inc.
Think Bioscience, Inc. BiotechnologyHealth Technology Develops small-molecule drugs | Health Technology |
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Operates as an clinical-stage biotechnology company that engages in discovery and development of medicines for neurological disorder | Health Technology |
Select your edition
All financial news and data tailored to specific country editions